Sen. Grassley Weighs In on the EpiPen Controversy

The transcript discusses the high cost of drugs, focusing on a specific product with a monopoly in the market. The conversation highlights the increasing use of adrenaline for peanut allergies and the lack of scientific analysis on the rise of such allergies. The senator addresses the potential for a hearing with Mylan, the company in question, and emphasizes the need for written communication before proceeding. The discussion also covers legislative efforts to introduce generic drugs faster and the importance of market-based competition over government price dictation. The senator aims to pressure Mylan to lower prices, criticizing their public relations approach and the ineffectiveness of their gift certificate solution.

What actions are being considered regarding the upcoming hearing and the company's response to pricing?

What legislative measures are being discussed to address the issue of drug pricing and accessibility?